AstraZeneca (AZN) Earnings Date, Estimates & Call Transcripts $68.95 +1.38 (+2.04%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$68.70 -0.25 (-0.36%) As of 05/12/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AstraZeneca Earnings Summary AstraZeneca issued Q1 2025 earnings on April 29, 2025, reporting an EPS of $1.24, which topped the consensus estimate of $1.10 by $0.14. Quarterly revenue rose 7.2% year-over-year to $13.59 billion, below analysts' expectations of $13.71 billion. With a trailing EPS of $2.49 and a P/E Ratio of 30.51, AstraZeneca's earnings are expected to grow 10.86% next year, from $4.51 to $5.00 per share. Upcoming Q2 Earnings DateJul. 24Before Market OpensEstimatedConsensus EPS (Apr. 29) $1.10 Actual EPS (Apr. 29) $1.24 Beat By $0.14 Actual Revenue (Apr. 29) $13.59BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Interim Report Slide DeckAZN Upcoming EarningsAstraZeneca's next earnings date is estimated for Thursday, July 24, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get AstraZeneca Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AstraZeneca and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAZN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AZN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AstraZeneca Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252$1.07$1.13$1.10Q2 20252$1.10$1.13$1.12Q3 20252$1.15$1.15$1.15Q4 20252$1.14$1.21$1.18 FY 2025 8 $4.46 $4.62 $4.54 Q1 20261$1.15$1.15$1.15Q2 20261$1.19$1.19$1.19Q3 20261$1.26$1.26$1.26Q4 20261$1.34$1.34$1.34 AstraZeneca Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/24/2025(Estimated)--------4/29/2025Q1 2025$1.10$1.24+$0.14$0.93$13.71B$13.59B2/6/2025Q4 2024$1.10$1.05 -$0.05$0.48$14.19B-11/12/2024Q3 2024$1.01$1.04+$0.03$1.62$13.08B$13.57B7/25/2024Q2 2024$0.98$0.99+$0.01$1.36$12.62B$12.45B4/25/2024Q1 2024$0.95$1.03+$0.08$1.36$11.92B$12.68B2/8/2024Q4 2023$0.74$0.73 -$0.01$1.15$12.07B$12.02B11/8/2023Q3 2023$0.84$0.87+$0.03$1.30$11.55B$11.49B7/28/2023Q2 2023$0.97$1.08+$0.11$1.57$11.06B$11.42B AstraZeneca Earnings - Frequently Asked Questions When is AstraZeneca's earnings date? AstraZeneca has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 24th, 2025 based off last year's report dates. Learn more on AZN's earnings history. Did AstraZeneca beat their earnings estimates last quarter? In the previous quarter, AstraZeneca (NASDAQ:AZN) reported $1.24 earnings per share (EPS) to beat the analysts' consensus estimate of $1.10 by $0.14. Learn more on analysts' earnings estimate vs. AZN's actual earnings. How can I listen to AstraZeneca's earnings conference call? The conference call for AstraZeneca's latest earnings report can be listened to online. Listen to Conference Call How can I read AstraZeneca's conference call transcript? The conference call transcript for AstraZeneca's latest earnings report can be read online. Read Transcript How much revenue does AstraZeneca generate each year? AstraZeneca (NASDAQ:AZN) has a recorded annual revenue of $54.98 billion. How much profit does AstraZeneca generate each year? AstraZeneca (NASDAQ:AZN) has a recorded net income of $7.04 billion. AZN has generated $2.49 earnings per share over the last four quarters. What is AstraZeneca's price-to-earnings ratio? AstraZeneca (NASDAQ:AZN) has a trailing price-to-earnings ratio of 30.51 and a forward price-to-earnings ratio of 15.29. The price/earnings-to-growth ratio is 1.42. What is AstraZeneca's EPS forecast for next year? AstraZeneca's earnings are expected to grow from $4.51 per share to $5.00 per share in the next year, which is a 10.86% increase. More Earnings Resources from MarketBeat Related Companies NVO Earnings Results NVS Earnings Results SNY Earnings Results GSK Earnings Results TAK Earnings Results ARGX Earnings Results ONC Earnings Results BNTX Earnings Results SMMT Earnings Results TEVA Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NASDAQ:AZN) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts